This statistic depicts the top ten initial public offerings ( IPOs ) and follow-ons in the cell and gene therapy industry in 2019 , by amount raised . During this year , the highest offerings were follow-on offerings with CRISPR Tx 's raise of 274 million U.S. dollars , and uniQure 's raise of 225 million U.S. dollars .
